Public Health Cannabis Monitoring and Surveillance in an Era of Legalization скачать в хорошем качестве

Public Health Cannabis Monitoring and Surveillance in an Era of Legalization

Featuring Susan Weiss, Director, Division of Extramural Research, NIDA; Hanan Abramovici, Manager and Senior Science Advisor, Office of Science and Surveillance, Cannabis Legalization and Regulation Branch, Health Canada; Julia Dilley , Ph.D.,M.E.S., Senior Research Scientist/Epidemiologist, Multnomah County & Oregon Public Health Division; Althea Grant-Lenzy , Ph.D., Senior Science Advisor to Deputy Director for Non-Infectious Diseases, Centers for Disease Control and Prevention and Gillian Schauer , M.P.H.,Ph.D., Senior Consultant to the National Institute on Drug Abuse and the Centers for Disease Control and Prevention Founder, Multi-State Collaborative on Cannabis and Public Health. Legalization of cannabis for medical or adult use is expanding, in the United States and in other countries. This wave of policy change has coincided with an evolving array of available cannabis products, including some with very high concentrations of THC, and a softening of attitudes about cannabis consumption. Rigorous monitoring of cannabis use patterns, behaviors, and related impacts (i.e., public health surveillance) is critically important in this dynamic policy climate. This panel presentation, moderated by Dr. Susan Weiss, brings together a panel of national and international experts to discuss the most important considerations for cannabis surveillance to inform public health policy. Topics covered include: progress in cannabis monitoring and surveillance measures; important populations of focus; gaps and limitations in current surveillance systems; examples of how data can be used in U.S. states and abroad; and ways that cannabis research can inform broader population level surveillance (and vice versa). Recorded live at the 2019 North American Cannabis Summit.